Cytoplasmic islet cell antibodies remain valuable in defining risk of progression to type 1 diabetes in subjects with other islet autoantibodies

Pediatric Diabetes

Volumn 6, Issue 4, 2005, Pages 184-192

  Pietropaolo, Massimo ^a,b   Yu, Shui ^b   Libman, Ingrid M ^a   Pietropaolo, Susan L ^a   Riley, Karen ^a   LaPorte, Ronald E ^b   Drash, Allan L ^a   Mazumdar, Sati ^b   Trucco, Massimo ^a,b   Becker, Dorothy J ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Autoantibodies; Cytoplasmic ICAs; Islet autoimmunity; Type 1 diabetes

Indexed keywords

GLUTAMATE DECARBOXYLASE ANTIBODY; INSULIN ANTIBODY; PANCREAS ISLET CELL ANTIBODY;

ADOLESCENT; ADULT; ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; CYTOPLASM; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; JUVENILE DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PREDICTION; PREVALENCE; PRIORITY JOURNAL; RADIOIMMUNOASSAY; REGRESSION ANALYSIS; RISK FACTOR;

ADOLESCENT; ADULT; ANIMALS; AUTOANTIBODIES; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; DISEASE PROGRESSION; FAMILY; FEMALE; GLUTAMATE DECARBOXYLASE; HUMANS; INFANT; ISLETS OF LANGERHANS; ISOENZYMES; LONGITUDINAL STUDIES; MALE; PREVALENCE; RATS; RISK ASSESSMENT;

EID: 29544444313     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/j.1399-543X.2005.00127.x     Document Type: Article

References (39)

1. Bottazzo GF, Florin-Christensen A, Doniach D. islet cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet 1974: 1279-1282.
2. Pilcher C, Elliott RB. Improved sensitivity of islet cell cytoplasmic antibody assay in diabetics. Lancet 1984: 8390: 1352.
3. Eisenbarth GS. Type I diabetes mellitus: a chronic autoimmune disease. N Engl J Med 1986: 1360-1368.
4. Riley WJ, MacLaren NK, Krischer J et al. A prospective study of the development of diabetes in relatives of patients with insulin-dependent diabetes. N Engl J Med 1990: 1167-1172.
5. Lipton RB, Kocova M, Laporte RE et al. Autoimmunity and genetic factors contribute to the risk of insulin-dependent diabetes mellitus in families: islet cell antibodies and HLA DQ heterodimers. Am J Epidemiol 1992: 503-512.
6. Schatz D, Krischer J, Horne G et al. Islet cell antibodies predict insulin-dependent diabetes in United States school age children as powerfully as in unaffected relatives. J Clin Invest 1994: 2403-2407.
7. Hagopian WA, Sanjeevi CB, Kockum I et al. Glutamate decarboxylase-, insulin-, and islet cell-antibodies and HLA typing to detect diabetes in a general population-based study of Swedish children. J Clin Invest 1995: 1505-1511.
8. Bingley PJ, Williams AJ, Gale EA. Optimized autoantibody-based risk assessment in family members. Implications for future intervention trials. Diabetes Care 1999: 11: 1796-1801.
9. Bonifacio E, Boitard C, Gleichman H, Shattock MA, Molenaar JL, Bottazzo GF. Assessment of precision, concordance, specificity, and sensitivity of islet cell antibody measurements in 41 assays. Diabetologia 1990: 731-736.
10. Landin-Olsson M. Precision of the islet cell antibody assay depends on the pancreas. J Clin Lab Anal 1990: 289-294.
11. Bingley PJ, Christie MR, Bonifacio E et al. Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives. Diabetes 1994: 1304-1310.
12. Verge CF, Gianani R, Kawasaki E et al. Prediction of type I diabetes mellitus in first degree relatives using a combination of insulin, glutamic acid decarboxylase and ICA512bdc/IA-2 autoantibodies. Diabetes 1996: 926-933.
13. Libman IM, Laporte RE, Becker D, Dorman JS, Drash AL, Kuller L. Was there an epidemic of diabetes in nonwhite adolescents in Allegheny County, Pennsylvania? Diabetes Care 1998: 8: 1278-1281.
14. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979: 1039-1057.
15. Grubin CE, Daniels T, Toivola B et al. A novel radiobinding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM. Diabetologia 1994: 344-350.
16. Pietropaolo M, Peakman M, Pietropaolo SL et al. Combined analysis of GAD65 and ICA512 (IA-2) autoantibodies in organ and non-organ specific autoimmune diseases confers high specificity for insulin-dependent diabetes mellitus. J Autoimmun 1998: 1-10.
17. DPT-1 Study Group. The Diabetes Prevention Trial-type 1diabetes (DPT-1): implementation of screening and staging of relatives. Transplant Proc 1995: 6: 3377.
18. Pietropaolo M, Becker DJ, Laporte RE et al. Progression to insulin-requiring diabetes in seronegative prediabetic subjects. the role of two HLA-DQ high risk haplotypes. Diabetologia 2002: 66-76.
19. Heinze G, Gnant M, Schemper M. Exact log-rank tests for unequal follow-up. Biometrics 2003: 4: 1151-1157.
20. Metha C, Patel N. StatXact 5 User Manual. Cambridge, MA, USA: Cytel Software Corporation, 2002.
21. Krischer JP, Cuthbertson DD, Yu L et al. Screening strategies for the identification of multiple antibody-positive relatives of individuals with Type 1 diabetes. J Clin Endocrinol Metab 2003: 1: 103-108.
22. Pilcher CC, Elliott RB. A sensitive and reproducible method for the assay of human islet cell antibodies. J Immunol Methods 1990: 1: 111-117.
23. Bonifacio E, Bingley PJ, Shattock M et al. Quantification of islet cell antibodies and prediction of insulin-dependent diabetes. Lancet 1990: 147-149.
24. Greenbaum CJ, Palmer JP, Nagataki S et al. and Participating Laboratories. Improved specificity of ICA assays in the fourth international immunology of diabetes exchange workshop. Diabetes 1992: 1570-1574.
25. Gianani R, Pugliese A, Bonner-Weir S et al. Prognostically significant heterogeneity of cytoplasmic islet cell antibodies in relatives of patients with type 1 diabetes. Diabetes 1992: 347-353.
26. Genovese S, Bonifacio E, McNally JM et al. Distinct cytoplasmic islet cell antibodies with different risks for type I (insulin-dependent) diabetes mellitus. Diabetologia 1992: 385-388.
27. Atkinson MA, Kaufman DL, Newman D, Tobin AJ, MacLaren NK. Islet cell cytoplasmic autoantibody reactivity to glutamate decarboxylase in insulin-dependent diabetes. J Clin Invest 1993: 350-356.
28. Bonifacio E, Lampasona V, Genovese S, Ferrari M, Bosi E. Identification of protein tyrosine phosphatase-like IA2 (islet cell antigen 512) as the insulin-dependent diabetes-related 37/40K autoantigen and a target of islet cell antibodies. J Immunol 1995: 11: 5419-5426.
29. Pietropaolo M, Eisenbarth GS. Autoantibodies in human diabetes. Curr Dir Autoimmun 2001: 252-282.
30. Myers MA, Rabin DU, Rowley MJ. Pancreatic islet cell cytoplasmic antibody in diabetes is represented by antibodies to islet cell antigen 512 and glutamic acid decarboxylase. Diabetes 1995: 11: 1290-1295.
31. Nayak RC, Omar MAK, Rabizadeh A, Srikanta S, Eisenbarth GS. 'Cytoplasmic' islet cell antibodies: evidence that the target antigen is a sialoglycoconjugate. Diabetes 1985: 617-619.
32. Dotta F, Previti M, Lenti L, Dionisi S et al. GM2-1 pancreatic islet ganglioside: identification and characterization of a novel islet-specific molecule. Diabetologia 1995: 9: 1117-1121.
33. Colman PG, Nayak RC, Campbell IL, Eisenbarth GS. Binding of cytoplasmic islet cell antibodies is blocked by human pancreatic glycolipid extracts. Diabetes 1988: 645-652.
34. Scott-Morgan L, Keller U et al. Insulin autoantibodies (IAA) may cause false positive islet cell antibody (ICA) results in the indirect immunofluorescence test. Diabetes Res 1988: 1: 45-48.
35. Eisenbarth GS, Jackson RA, Pugliese A. Insulin autoimmunity: the rate limiting factor in pre-type I diabetes. J Autoimmun 1992: 241-246.
36. Achenbach P, Warncke K, Reiter J et al. Stratification of type 1 diabetes risk on the basis of islet autoantibody characteristics. Diabetes 2004: 2: 384-392.
37. Arslanian SL, Becker DJ, Rabin B et al. Correlates of insulin antibodies in newly diagnosed children with insulin-dependent diabetes before insulin therapy. Diabetes 1985: 926-930.
38. + relatives. The ICARUS Data Set. Diabetes 1996: 1720-1728.
39. Mrena S, Savola K, Kulmala P, Akerblom HK, Knip M. Staging of preclinical type 1 diabetes in siblings of affected children. Childhood Diabetes Finland Study Group Pediatrics 1999: 4 Part 1: 925-930.